tiprankstipranks
Amphastar Pharmaceuticals (AMPH)
NASDAQ:AMPH
US Market
AMPH
Amphastar Pharmaceuticals
RESEARCH TOOLSreports
Want to see AMPH full AI Analyst Report?

Amphastar Pharmaceuticals (AMPH) Income Statement

432 Followers

Amphastar Pharmaceuticals Income Statement

Last quarter (Q4 2025), Amphastar Pharmaceuticals's total revenue was $183.10M, a decrease of -1.83% from the same quarter last year. In Q4, Amphastar Pharmaceuticals's net income was $24.43M. See Amphastar Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 719.89M$ 731.97M$ 644.39M$ 498.99M$ 437.77M
Gross Profit
$ 356.06M$ 373.86M$ 351.12M$ 248.86M$ 199.74M
Operating Expenses
$ 215.65M$ 168.44M$ 154.13M$ 141.36M$ 129.85M
Depreciation and Amortization
$ 0.00$ 57.20M$ 41.78M$ 28.27M$ 26.53M
EBITDA
$ 149.10M$ 277.31M$ 240.29M$ 146.16M$ 111.56M
Operating Income
$ 140.40M$ 205.42M$ 196.99M$ 107.50M$ 69.89M
Other Income/Expenses
$ -16.78M$ -16.23M$ -27.61M$ 7.37M$ 14.04M
Pretax Income
$ 123.62M$ 189.19M$ 169.38M$ 114.86M$ 83.93M
Net Income
$ 98.09M$ 159.52M$ 137.54M$ 91.39M$ 62.12M
Per Share Metrics
Basic EPS
$ 2.10$ 3.29$ 2.85$ 1.88$ 1.30
Diluted EPS
$ 2.03$ 3.06$ 2.60$ 1.74$ 1.25
Weighted Average Shares Outstanding
 46.74M 48.43M 48.27M 48.55M 47.78M
Weighted Average Shares Outstanding (Diluted)
 48.22M 52.06M 53.00M 52.43M 49.78M
Currency in USD

Amphastar Pharmaceuticals Earnings and Revenue History